Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-26 @ 12:23 AM
NCT ID:
NCT03165994
Pre Assignment Details:
The study consisted of:
* Screening Period (within 28 days of Treatment Period Day 1).
* Treatment Period (Weeks 1-6) sotigalimab with standard-of-care (SOC) chemoradiation (chemoRT) consisting of external beam radiation in daily fractions, with concurrent weekly low-dose carboplatin/paclitaxel.
* Post-treatment Period inc. surgery (Weeks 7-17).
* Post-operative Follow-up Period (Months 1, 3, and 6 post-operatively).
* Overall Survival Follow-up Period (every 3 months for 18 months).
Recruitment Details:
A total of 34 participants were eligible for the study, of which 33 received treatment in the study, in the United States between October 2017 and February 2023.
Study:
NCT03165994
Study Brief:
Results Section:
NCT03165994